Publications


Content and Construct Validity, Reliability, and Responsiveness of the Rheumatoid Arthritis Flare Questionnaire: OMERACT 2016 Workshop Report.
J Rheumatol 2017 Aug 15. Epub 2017 Aug 15.
From McGill University, Montreal, Quebec; University of British Columbia, Vancouver, British Columbia, Canada; Johns Hopkins University, Baltimore, Maryland; Hospital for Special Surgery, New York, New York; University of California, Los Angeles; Healthy Motivation, Santa Barbara, California, USA; Cardiff University, Cardiff; University of the West of England, Bristol, UK; Schlosspark-Klinik University Medicine, Berlin, Germany; Parker Institute, Copenhagen University, Copenhagen, Denmark; Sint Maartenskliniek, Nijmege; Vrije Universiteit (VU), Amsterdam, the Netherlands; Pierre et Marie Curie University, Paris; University of Lorraine, Lorraine, France; University of Sydney, Sydney, Australia. SJB, COB, VPB, ALL, and AL have received support from a Methods Award (SC14-1402-10818) and/or a Eugene Washington Dissemination Award (EAIN-1988) from the Patient Centered Outcomes Research Institute (PCORI). COB and work presented in this grant have been supported by P30-AR053503, Rheumatic Diseases Research Core Center, Human Subjects Research Core, funded by the US National Institutes of Health (NIH) and the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). Additional funding came from the Camille Julia Morgan Arthritis Research and Education Fund. VPB is supported by the Cedar Hill Foundation and by NIH grant 1UH2AR067691. RC and the Parker Institute are supported by grants from the Oak Foundation. SPB received support to attend OMERACT 2016 as the RA Flare Group fellow. UCB Inc. supported translation of the preliminary flare questionnaire into various linguistic and country-specific versions. UCB and Pfizer have incorporated the preliminary flare questionnaire into clinical trials for field testing. Pfizer (Germany) has provided unrestricted grants to support the efforts of the OMERACT Flare Working Group. All statements in this report, including its findings and conclusions, are solely those of the authors and do not necessarily represent the views of the NIH or NIAMS, or PCORI, its board of governors or methodology committee. S.J. Bartlett, PhD, McGill University, and Johns Hopkins University; S.P. Barbic, PhD, University of British Columbia; V.P. Bykerk, MD, Hospital for Special Surgery; E.H. Choy, MD, Cardiff University; R. Alten, MD, Schlosspark-Klinik University Medicine; R. Christensen, PhD, Parker Institute, Copenhagen University; A. den Broeder, MD, PhD, Sint Maartenskliniek; B. Fautrel, MD, PhD, Pierre et Marie Curie University; D.E. Furst, MD, University of California; F. Guillemin, MD, PhD, University of Lorraine; S. Hewlett, PhD, RN, University of the West of England; A.L. Leong, MBA, Healthy Motivation; A. Lyddiatt, Patient Research Partner; L. March, MD, PhD, University of Sydney; P. Montie, Patient Research Partner; C. Pohl, MD, Schlosspark-Klinik University Medicine; M. Scholte Voshaar, MSc, VU; T.G. Woodworth, MD, University of California; C.O. Bingham III, MD, Johns Hopkins University. Address correspondence to Dr. S.J. Bartlett, Royal Victoria Hospital, Department of Clinical Epidemiology, Ross R.31, 687 av des Pin Ouest, Montréal, Quebec H3A 1A1, Canada. E-mail: Accepted for publication May 31, 2017.


Montreal Accord on patient-reported outcomes (PRO) use series - paper 1: introduction.
J Clin Epidemiol 2017 Apr 19. Epub 2017 Apr 19.
Department of Medicine, McGill University/McGill University Health Center (RVH), 687 Pine Ave W R4.29, Montreal, Québec, Canada H3A 1A1; School of Physical and Occupational Therapy, McGill University, 3654 Prom Sir-William-Osler, Montreal, Québec, Canada H3G 1Y5; Centre de recherche interdisciplinaire en réadaptation (CRIR), Canada, Constance-Lethbridge Rehabilitation Center, 7005 Boulevard De Maisonneuve O, Montreal, Québec, Canada H4B 1T3.

Montreal Accord on patient-reported outcomes use series-paper 2: terminology proposed to measure what matters in health.
J Clin Epidemiol 2017 Apr 20. Epub 2017 Apr 20.
Department of Medicine, McGill University/McGill University Health Center, 687 Pine Ave W R4.29, Montreal, Quebec H3A 1A1, Canada; Division of Rheumatology, Johns Hopkins School of Medicine, 5200 Eastern Avenue #4100, Baltimore, MD 21224, USA.

Montreal accord on patient-reported outcomes use series-paper 6: creating national initiatives to support development and use-the PROMIS example.
J Clin Epidemiol 2017 Apr 20. Epub 2017 Apr 20.
Department of Medicine, McGill University/McGill University Health Center, 687 Pine Avenue W R4.29, Montreal, QC, Canada H3A 1A1; School of Physical and Occupational Therapy, McGill University, 3654 Prom Sir-William-Osler, Montreal, QC, Canada H3G 1Y5; Centre de recherche interdisciplinaire en réadaptation (CRIR), Constance-Lethbridge Rehabilitation Center, 7005 Boulevard De Maisonneuve Ouest, Montreal, QC, Canada H4B 1T3.

Montreal Accord on Patient-Reported Outcomes (PRO) use series - Paper 9: anonymization and ethics considerations for capturing and sharing patient reported outcomes.
J Clin Epidemiol 2017 Apr 20. Epub 2017 Apr 20.
Electronic Health Information Laboratory, Children's Hospital of Eastern Ontario Research Institute, 401 Smyth Road, Ottawa, Ontario K1H 8L1, Canada; Department of Pediatrics, Faculty of Medicine, University of Ottawa, 401 Smyth Road, Ottawa K1H 8L1, Canada. Electronic address:

Montreal Accord on patient-reported outcomes use series-paper 4: patient-reported outcomes can inform clinical decision making in chronic care.
J Clin Epidemiol 2017 Apr 20. Epub 2017 Apr 20.
Johns Hopkins Division of Rheumatology, 5200 Eastern Avenue, Mason F. Lord Bldg, Suite 4100, Baltimore, MD 21224, USA; Department of Medicine, McGill University/McGill University Health Center (RVH), 687 Pine Avenue West, Ross Pavilion R4.29, Montreal, Québec H3A 1A1, Canada.

Montreal Accord on Patient-Reported Outcomes (PRO) use series - Paper 5: patient-reported outcomes can be linked to epidemiologic measures to monitor populations and inform public health decisions.
J Clin Epidemiol 2017 Apr 21. Epub 2017 Apr 21.
Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, 1020 Pine Avenue West, Montreal, Quebec H3A 1A2, Canada. Electronic address:

Stiffness Is the Cardinal Symptom of Inflammatory Musculoskeletal Diseases, Yet Still Variably Measured: Report from the OMERACT 2016 Stiffness Special Interest Group.
J Rheumatol 2016 Dec 15. Epub 2016 Dec 15.
From the Department of Nursing and Midwifery, University of the West of England; University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol; Leeds Institute of Rheumatic and Musculoskeletal Medicine, Leeds; Department of Rheumatology, Ashford and St. Peter's National Health Service (NHS) Foundation Trust, Chertsey; Patient Research Partner PMR-GCA Scotland, Forest Lodge, Foulden, Berwickshire, UK; Institute of Bone and Joint Research, Kolling Institute, Northern Sydney Local Health District; Department of Rheumatology, Royal North Shore Hospital, New South Wales; University of Sydney, Sydney; Rheumatology Unit, The Queen Elizabeth Hospital, Adelaide; Discipline of Medicine, University of Adelaide, Adelaide, Australia; Division of Clinical Epidemiology, Division of Rheumatology, and Division Respiratory Epidemiology, McGill University/McGill University Health Centers, Montreal, Québec; Patient Research Partner, Toronto Western Hospital, Toronto; Cochrane Musculoskeletal Group, Institute of Population Health, Ottawa, Ontario, Canada; Division of Rheumatology, Johns Hopkins School of Medicine, Baltimore, Maryland; University of Illinois-Chicago, Chicago, Illinois; Healthy Motivation and Global Alliance for Musculoskeletal Health the Bone and Joint Decade, Santa Barbara, California, USA; Schlosspark-Klinik, University Medicine Berlin, Berlin, Germany; Horizon Pharma LTD, Dublin, Ireland; Department of Rheumatology and Immunology, Singapore General Hospital, Singapore. Attendance to OMERACT of 1 working group fellow and 1 patient research partner was supported by a research grant (to OMERACT) from Horizon Pharma. As part of the supplement series OMERACT 13, this report was reviewed internally and approved by the Guest Editors for integrity, accuracy, and consistency with scientific and ethical standards. S. Halls, PhD, Department of Nursing and Midwifery, University of the West of England; P. Sinnathurai, BSc(Med) MBBS, FRACP, Institute of Bone and Joint Research, Kolling Institute, Northern Sydney Local Health District, and Department of Rheumatology, Royal North Shore Hospital, and University of Sydney; S. Hewlett, PhD, RN, Department of Nursing and Midwifery, University of the West of England; S.L. Mackie, BM, BCh, PhD, Leeds Institute of Rheumatic and Musculoskeletal Medicine; L. March, MD, Institute of Bone and Joint Research, Kolling Institute, Northern Sydney Local Health District, and Department of Rheumatology, Royal North Shore Hospital, and University of Sydney; S.J. Bartlett, MD, Division of Clinical Epidemiology, Division of Rheumatology, and Division Respiratory Epidemiology, McGill University/McGill University Health Centers, and Division of Rheumatology, Johns Hopkins School of Medicine; C.O. Bingham III, MD, Division of Rheumatology, Johns Hopkins School of Medicine; R. Alten, MD, Schlosspark-Klinik, University Medicine Berlin; I. Campbell, BEd LLB, Patient Research Partner, Toronto Western Hospital; C.L. Hill, MBBS, MD, MSc, FRACP, Staff Specialist, Rheumatology Unit, The Queen Elizabeth Hospital, and Discipline of Medicine, University of Adelaide; R.J. Holt, PharmD, MBA, University of Illinois-Chicago, and Horizon Pharma LTD; R. Hughes, MA, MD, FRCP, Department of Rheumatology, Ashford and St. Peter's NHS Foundation Trust; J.R. Kirwan, MD, Department of Nursing and Midwifery, University of the West of England, and University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary; A.L. Leong, MBA, Patient Partner, Healthy Motivation and Global Alliance for Musculoskeletal Health the Bone and Joint Decade; Y.Y. Leung, MD, Assistant Professor, Department of Rheumatology and Immunology, Singapore General Hospital; A. Lyddiatt, Patient Research Partner, Cochrane Musculoskeletal Group, Institute of Population Health; L.M. Neill, BSc, CPhys, MInstP, Patient Research Partner, Trustee and Secretary, PMR-GCA Scotland; A.M. Morbai, MD, MHS, Division of Rheumatology, Johns Hopkins University School of Medicine. Address correspondence to Dr. S. Halls, Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, BS2 8HW, UK. E-mail:




Examination of the association of sex and race/ethnicity with appearance concerns: a Scleroderma Patient-centered Intervention Network (SPIN) Cohort study.
Clin Exp Rheumatol 2016 Sep-Oct;34 Suppl 100(5):92-99. Epub 2016 Aug 1.
Lady Davis Inst.Med.Res, Jewish Gen.Hosp; Depts. Educational & Counselling Psychology, Psychiatry, McGill Univ; Dept.of Medicine, McGill Univ; Depts. Psychology, Epidemiology, Biostats & Occupational Health, School Nursing, McGill Univ, Montreal, Canada.

Identifying flares in rheumatoid arthritis: reliability and construct validation of the OMERACT RA Flare Core Domain Set.
RMD Open 2016 26;2(1):e000225. Epub 2016 May 26.
Division of Rheumatology, Johns Hopkins School of Medicine, Baltimore, Maryland, USA; Divisions of Clinical Epidemiology, Rheumatology, and Respiratory Clinical Trials Unit, McGill University, Montreal, Québec, Canada.


Feasibility and Domain Validation of Rheumatoid Arthritis (RA) Flare Core Domain Set: Report of the OMERACT 2014 RA Flare Group Plenary.
J Rheumatol 2015 Nov 15;42(11):2185-9. Epub 2015 Feb 15.
From McGill University, Montreal, Quebec, Canada; Johns Hopkins University, Baltimore, Maryland; Hospital for Special Surgery, New York, New York, USA; Swansea University, Swansea; Cardiff University, Cardiff, UK; Schlosspark-Klinik, University Medicine Berlin, Berlin, Germany; The Parker Institute, Copenhagen University Hospital at Frederiksberg, Copenhagen, Denmark; University of California, Los Angeles, California, USA; University of Lorraine, Nancy, France; University of the West of England, Bristol, UK; Healthy Motivation, Santa Barbara, California, USA; University of Sydney, Sydney, Australia; and University of Twente, Enschede, The Netherlands.S.J. Bartlett, PhD, McGill University; and Johns Hopkins University; V.P. Bykerk, MD, Hospital for Special Surgery; R. Cooksey, MSc, Swansea University; E.H. Choy, MD, Cardiff University; R. Alten, Schlosspark-Klinik, University Medicine Berlin; R. Christensen, PhD, Parker Institute, Copenhagen University Hospital at Frederiksberg; D.E. Furst, MD, University of California, Los Angeles; F. Guillemin, MD, PhD, University of Lorraine; S. Halls, MSc; S. Hewlett, PhD, RN, University of the West of England; A.L. Leong, Healthy Motivation; A. Lyddiatt; University of Sydney; L. March, MD, PhD; P. Montie; A.M. Orbai, MD, MHS, Johns Hopkins University; C. Pohl, MD, Schlosspark-Klinik, University Medicine; M. Scholte Voshaar, University of Twente; T.G. Woodworth, MD, University of California, Los Angeles; and C.O. Bingham 3rd, MD, Johns Hopkins University.

Optimal Strategies for Reporting Pain in Clinical Trials and Systematic Reviews: Recommendations from an OMERACT 12 Workshop.
J Rheumatol 2015 Oct 15;42(10):1962-1970. Epub 2015 May 15.
From the Michael G. DeGroote Institute for Pain Research and Care, McMaster University; Department of Anesthesia, McMaster University; Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario; Department of Medicine, McGill University, Divisions of Rheumatology and Clinical Epidemiology, Royal Victoria Hospital, Montreal, Quebec, Canada; Paris Descartes University, APHP Cochin Hospital, Rheumatology Department, Cochin Hospital, INSERM (U1153) Clinical Epidemiology and Biostatistics, PRES Sorbonne Paris-Cité, Paris, France; The Hospital for Sick Children Research Institute, Toronto; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto; Department of Anesthesia and Pain Medicine, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada; University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; University of Pittsburgh and Veterans Affairs (VA) Pittsburgh Healthcare System, Pittsburgh, Pennsylvania, USA; Institute of Population Health, University of Ottawa, Ottawa, Ontario, Canada; Pain Research, University of Oxford, Nuffield Division of Anaesthetics, The Churchill, Oxford, UK; Birmingham VA Medical Center and University of Alabama at Birmingham, Birmingham, Alabama; Inflammation and Immunology Clinical Research, Celgene Corporation, Summit, New Jersey; Department of Medicine, Division of Rheumatology, the State University of New Jersey, New Brunswick, New Jersey; Division of Immunology/Rheumatology, Stanford University, Palo Alto, California; University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Department of Medicine, Faculty of Medicine, Institute of Population Health, University of Ottawa; Ottawa Hospital Research Institute, Clinical Epidemiology Program; Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Ontario, Canada.

Yoga in Sedentary Adults with Arthritis: Effects of a Randomized Controlled Pragmatic Trial.
J Rheumatol 2015 Jul 1;42(7):1194-202. Epub 2015 Apr 1.
From the Maryland University of Integrative Health, Laurel; Department of Medicine, and School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA; Division of Clinical Epidemiology, Royal Victoria Hospital, McGill University, Montreal, Quebec, Canada.S.H. Moonaz, PhD, Maryland University of Integrative Health; C.O. Bingham III, MD, Department of Medicine, Division of Rheumatology, Johns Hopkins University; L. Wissow, MD, MPH, School of Public Health, Johns Hopkins University; S.J. Bartlett, PhD, Associate Professor of Medicine, Division of Clinical Epidemiology, Royal Victoria Hospital, McGill University.

Updating the OMERACT filter: implications for patient-reported outcomes.
J Rheumatol 2014 May 1;41(5):1011-5. Epub 2014 Mar 1.
From the University of Bristol, Academic Rheumatology Unit, and the University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Department of Medicine, McGill University, Montreal, Quebec, Canada; Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA; Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Departments of Epidemiology and Biostatistics, and Rheumatology, and Department of Medical Humanities, VU University Medical Center, Amsterdam, The Netherlands; National Rheumatoid Arthritis Society, Maidenhead, Berkshire, UK; Faculty of Health Sciences, University of Queensland, Royal Brisbane and Women's Hospital, Herston, Brisbane, Australia; Section of Rheumatology, Cardiff University School of Medicine, Cardiff, UK; Université de Lorraine, Université Paris Descartes, Paris, France; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen, Amsterdam, The Netherlands; Healthy Motivation, Bone and Joint Decade, Santa Barbara, California, USA; Cochrane Musculoskeletal Group, Institute of Population Health, Ottawa, Ontario, Canada; Department of Rheumatology, Royal North Shore Hospital, St. Leonards, New South Wales, Australia; Consumer Advisory Board, Arthritis Research Centre of Canada, Richmond, British Columbia, Canada; UCB Pharma S.A., Brussels, Belgium; Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA; Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada; Université Pierre et Marie Curie (UPMC) - Paris 6, GRC-UMPC 08 (EEMOIS); AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France.

Establishing a core domain set to measure rheumatoid arthritis flares: report of the OMERACT 11 RA flare Workshop.
J Rheumatol 2014 Apr 1;41(4):799-809. Epub 2014 Mar 1.
From the Department of Rheumatology, Hospital for Special Surgery, New York, New York, USA; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Johns Hopkins University, Baltimore, Maryland, USA; McGill University, Montreal, Quebec, Canada; Schlosspark Klinik, Charité University Medicine, Berlin, Germany; Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center and Caphri Research Institute, Maastricht, The Netherlands; Musculoskeletal Statistics Unit, The Parker Institute, Department of Rheumatology, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Denmark; David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California, USA; University of the West of England, Bristol, UK; Healthy Motivation, Bone and Joint Decade, Santa Barbara, California, USA; Musculoskeletal Group, Cochrane Collaboration; University of Sydney Department of Rheumatology, Royal North Shore Hospital, St. Leonards, Australia; National Fathers' Network, Seattle, Washington, USA; Arthritis Research Center, Vancouver, British Columbia, Canada; Tools2use.eu, Bussum, The Netherlands; and the Department of Rheumatology, Cardiff University, Cardiff, UK.






Randomized trial of the effect of drug presentation on asthma outcomes: the American Lung Association Asthma Clinical Research Centers.
J Allergy Clin Immunol 2009 Sep 25;124(3):436-44, 444e1-8. Epub 2009 Jul 25.
Division of Pulmonary and Critical Care Medicine, Department of Medicine, the Johns Hopkins University School of Medicine, Baltimore, Md 21224, USA.

OF